keyword
MENU ▼
Read by QxMD icon Read
search

Clomipramine and parkinson

keyword
https://www.readbyqxmd.com/read/27073741/repurposing-psychiatric-medicines-to-target-activated-microglia-in-anxious-mild-cognitive-impairment-and-early-parkinson-s-disease
#1
REVIEW
Edward C Lauterbach
Anxiety is common in the Mild Cognitive Impairment (MCI) stage of Alzheimer's disease (AD) and the pre-motor stages of Parkinson's disease (PD). A concomitant and possible cause of this anxiety is microglial activation, also considered a key promoter of neurodegeneration in MCI and early PD via inflammatory mechanisms and the generation of degenerative proinflammatory cytokines. Psychiatric disorders, prevalent in AD and PD, are often treated with psychiatric drugs (psychotropics), raising the question of whether psychotropics might therapeutically affect microglial activation, MCI, and PD...
2016: American Journal of Neurodegenerative Disease
https://www.readbyqxmd.com/read/26791104/effect-of-tricyclic-antidepressants-on-l-dopa-induced-dyskinesia-and-motor-improvement-in-hemi-parkinsonian-rats
#2
Melissa M Conti, Adam A A Goldenberg, Alexandra Kuberka, Mohamed Mohamed, Satie Eissa, David Lindenbach, Christopher Bishop
Although dopamine replacement therapy with L-DOPA in Parkinson's disease initially reduces motor symptoms, its chronic use often leads to the development of abnormal involuntary movements known as L-DOPA-induced dyskinesia. Increasingly, research has indicated that non-dopaminergic neurons gain function in the parkinsonian brain, taking up and converting L-DOPA to dopamine and releasing it as a "false neurotransmitter". Although less explored, promiscuity between monoamine transporters may also modulate these processes...
March 2016: Pharmacology, Biochemistry, and Behavior
https://www.readbyqxmd.com/read/24725285/parkinsonism-and-severe-hypothyroidism-in-an-elderly-patient-a-case-of-lithium-toxicity-due-to-pharmacological-interactions
#3
G Basile, A Epifanio, R Mandraffino, G Trifirò
WHAT IS KNOWN AND OBJECTIVE: Hypothyroidism is a common clinical side effect of lithium treatment, whereas parkinsonism is a very rare adverse event. A number of case series of clinical signs of reversible and permanent parkinsonism due to lithium toxicity have been previously published, but never in association with hypothyroidism. We describe a rare clinical case of concurrent reversible parkinsonism and severe hypothyroidism due to lithium toxicity. CASE SUMMARY: The patient was a 74-year-old woman chronically treated with carbonate lithium (300 mg, twice daily) and clomipramine (75 mg, once daily); she also received valsartan (160 mg) plus hydrochlorothiazide (12·5 mg), once daily...
August 2014: Journal of Clinical Pharmacy and Therapeutics
https://www.readbyqxmd.com/read/18806237/treatment-for-late-onset-obsessive-compulsive-disorder-with-parkinsonism
#4
Arunlata Agarwal, Devdutta Biswas, Raja Sadhu
Dysfunction of the basal ganglia and frontal subcortical structures occurs in both obsessive-compulsive disorder and parkinsonism. Treatment of obsessive-compulsive disorder with parkinsonism is a therapeutic challenge, especially in old age as selective serotonin reuptake inhibitors may aggravate motor symptoms and worsen clinical conditions. The authors present a series of patients with late onset obsessive-compulsive disorder demonstrating improvement in obsessive-compulsive disorder as well as parkinsonian signs...
2008: Journal of Neuropsychiatry and Clinical Neurosciences
https://www.readbyqxmd.com/read/18665659/pathophysiology-and-treatment-of-psychosis-in-parkinson-s-disease-a-review
#5
REVIEW
Laura B Zahodne, Hubert H Fernandez
Psychotic symptoms in Parkinson's disease (PD) are relatively common and, in addition to creating a disturbance in patients' daily lives, have consistently been shown to be associated with poor outcome. Our understanding of the pathophysiology of psychosis in PD has expanded dramatically over the past 15 years, from an initial interpretation of symptoms as dopaminergic drug adverse effects to the current view of a complex interplay of extrinsic and disease-related factors.PD psychosis has unique clinical features, namely that it arises within a context of a clear sensorium and retained insight, there is relative prominence of visual hallucinations and progression occurs over time...
2008: Drugs & Aging
https://www.readbyqxmd.com/read/18639562/inhibition-of-glial-inflammatory-activation-and-neurotoxicity-by-tricyclic-antidepressants
#6
Jaegyu Hwang, Long Tai Zheng, Jiyeon Ock, Maan Gee Lee, Sang-Hyun Kim, Ho-Won Lee, Won-Ha Lee, Hae-Chul Park, Kyoungho Suk
Glial activation and neuroinflammatory processes play an important role in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and HIV dementia. Activated glial cells can secrete various proinflammatory cytokines and neurotoxic mediators, which may contribute to neuronal cell death. Inhibition of glial activation may alleviate neurodegeneration under these conditions. In the present study, the antiinflammatory and neuroprotective effects of tricyclic antidepressants were investigated using cultured brain cells as a model...
October 2008: Neuropharmacology
https://www.readbyqxmd.com/read/16919377/antidepressant-use-in-treatment-of-psychosis-with-comorbid-depression-in-parkinson-s-disease
#7
Giuseppe Meco, Silvia Bernardi
The authors report an improvement in delusions and hallucinations after antidepressant treatment (Clomipramine) in a parkinsonian patient with psychosis and comorbid depression. Their findings, which support a previous case treated with Citalopram, highlight the possible effectiveness of antidepressant therapy on psychotic symptoms in parkinsonian patients.
January 30, 2007: Progress in Neuro-psychopharmacology & Biological Psychiatry
https://www.readbyqxmd.com/read/9567763/haloperidol-induced-catalepsy-a-model-for-screening-antidepressants-effective-in-treatment-of-depression-with-parkinson-s-disease
#8
R T Khisti, S N Mandhane, C T Chopde
Incidence of severe depression is very common in Parkinson's disease (PD). Use of antidepressants in such cases is known to improve or worsen the existing PD. However, prediction of the effect of antidepressant on symptoms of PD is limited due to lack of suitable animal model. The present study examines the possibility of using haloperidol-induced catalepsy model in rats for this purpose. Antidepressants showed distinct effect on haloperidol-induced catalepsy, although most of them reduced forced-swimming induced immobility...
December 1997: Indian Journal of Experimental Biology
https://www.readbyqxmd.com/read/7885518/-a-case-of-rare-side-effects-of-certain-antidepressive-drugs
#9
T Haenel, H R Stöckli, P Truog
Because of a depressive syndrome, a 39-year-old patient received 20 mg fluoxetine per day. Approximately 4 weeks later, treatment with this drug was stopped after the patient had complained of worsening tremor, particularly of the upper extremities. In addition, accommodation difficulties and problems with word-finding had appeared shortly before. The symptoms became worse after fluoxetine had been discontinued. Treatment of the side effects with piperiden and bromazepam brought about no real improvement in the patient's condition...
January 1995: Der Nervenarzt
https://www.readbyqxmd.com/read/3258627/suppression-of-1-methyl-4-phenyl-1-2-3-6-tetrahydropyridine-mptp-induced-dopaminergic-neurotoxicity-in-mouse-brain-by-piroheptine-and-trihexyphenidyl
#10
T Saitoh
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces a parkinsonian state in monkeys and humans and a marked 3,4-dihydroxyphenylethylamine (dopamine) depletion in mouse striatum. In this study, we found that pretreatment with 3-(10,11,-dihydro-5H-dibenzo-[a,d]-cycloheptan-5-ylidene)-1-ethyl- 2- methylpyrrolidine (piroheptine), an anticholinergic drug which also inhibits dopamine uptake completely prevented loss of striatal dopamine in MPTP-treated mice. Trihexyphenidyl partially protected against the neurotoxicity of MPTP...
February 1988: Journal of the Neurological Sciences
https://www.readbyqxmd.com/read/3099590/the-role-of-the-central-monoaminergic-system-and-rapid-eye-movement-sleep-in-development
#11
M Mirmiran
Transmission of information in the brain is of a chemical nature. Neurotransmitters are present at very early stages of brain development, having trophic effects on maturation of target neurons as well as mediating the behavioral repertoire of the immature brain. Many centrally acting psychoactive drugs which are commonly used (also during pregnancy) for treatment of depression, asthma, hypertension, epilepsy, parkinsonism, hyperkinetism and other neurological and psychiatric disorders act directly on brain neurotransmitters (in particular monoamines) and behavioral states...
1986: Brain & Development
https://www.readbyqxmd.com/read/2022757/distribution-of-catecholamine-uptake-sites-in-human-brain-as-determined-by-quantitative-3h-mazindol-autoradiography
#12
G A Donnan, S J Kaczmarczyk, G Paxinos, P J Chilco, R M Kalnins, D G Woodhouse, F A Mendelsohn
Because of the importance of the catecholamine system in Parkinson's disease and its relevance to a variety of clinical movement disorders, catecholamine uptake sites were mapped in the human brain using [3H] mazindol autoradiography. Displacement studies with known dopamine (DA) and noradrenaline (NA) uptake blockers showed that binding in the striatum was to dopamine uptake sites; binding in the locus coeruleus was to noradrenergic uptake sites. By using the selective noradrenergic uptake blocker desmethylimipramine (DMI), a comprehensive map of both DA and NA uptake sites was generated...
February 15, 1991: Journal of Comparative Neurology
https://www.readbyqxmd.com/read/1459499/-withdrawal-reactions-after-clomipramine
#13
Z Zemishlany, D Aizenberg, H Hermesh, A Weizman
Abrupt or gradual discontinuation of tricyclic antidepressants may precipitate withdrawal symptoms. The most common of these are general somatic or gastrointestinal distress, anxiety and agitation, sleep disturbance, akathisia, parkinsonism, paradoxical behavioral activation and mania. There are very few reports of withdrawal reactions following discontinuation of clomipramine since it has not been in use in the US until recently. 2 patients with withdrawal symptoms following discontinuation of clomipramine are presented...
October 1992: Harefuah
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"